Literature DB >> 29986895

Delineating the Physiological Roles of the PE and Catalytic Domains of LipY in Lipid Consumption in Mycobacterium-Infected Foamy Macrophages.

Pierre Santucci1, Sadia Diomandé1, Isabelle Poncin1, Laetitia Alibaud2, Albertus Viljoen3, Laurent Kremer3,4, Chantal de Chastellier5, Stéphane Canaan6.   

Abstract

Within tuberculous granulomas, a subpopulation of Mycobacterium tuberculosis resides inside foamy macrophages (FM) that contain abundant cytoplasmic lipid bodies (LB) filled with triacylglycerol (TAG). Upon fusion of LB with M. tuberculosis-containing phagosomes, TAG is hydrolyzed and reprocessed by the bacteria into their own lipids, which accumulate as intracytosolic lipid inclusions (ILI). This phenomenon is driven by many mycobacterial lipases, among which LipY participates in the hydrolysis of host and bacterial TAG. However, the functional contribution of LipY's PE domain to TAG hydrolysis remains unclear. Here, enzymatic studies were performed to compare the lipolytic activities of recombinant LipY and its truncated variant lacking the N-terminal PE domain, LipYPE). Complementarily, an FM model was used where bone marrow-derived mouse macrophages were infected with M. bovis BCG strains either overexpressing LipY or LipYPE) or carrying a lipY deletion mutation prior to being exposed to TAG-rich very-low-density lipoprotein (VLDL). Results indicate that truncation of the PE domain correlates with increased TAG hydrolase activity. Quantitative electron microscopy analyses showed that (i) in the presence of lipase inhibitors, large ILI (ILI+3) were not formed because of an absence of LB due to inhibition of VLDL-TAG hydrolysis or inhibition of LB-neutral lipid hydrolysis by mycobacterial lipases, (ii) ILI+3 profiles in the strain overexpressing LipYPE) were reduced, and (iii) the number of ILI+3 profiles in the ΔlipY mutant was reduced by 50%. Overall, these results delineate the role of LipY and its PE domain in host and mycobacterial lipid consumption and show that additional mycobacterial lipases take part in these processes.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  M. bovis BCG; Mycobacterium tuberculosis; electron microscopy; intracytosolic lipid inclusions; lipase; lipase inhibitor; lipid bodies; lipolysis; lipolytic enzymes

Mesh:

Substances:

Year:  2018        PMID: 29986895      PMCID: PMC6105901          DOI: 10.1128/IAI.00394-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

Review 1.  Lipid hydrolizing enzymes in virulence: Mycobacterium tuberculosis as a model system.

Authors:  Gurdyal Singh; Gurpreet Singh; Dipendrasinh Jadeja; Jagdeep Kaur
Journal:  Crit Rev Microbiol       Date:  2010-08       Impact factor: 7.624

2.  Mycobacteria and the greasy macrophage: getting fat and frustrated.

Authors:  Olivier Neyrolles
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

Review 3.  The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes.

Authors:  Robert H Nelson; John M Miles
Journal:  Expert Opin Pharmacother       Date:  2005-11       Impact factor: 3.889

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities.

Authors:  Peng-Yu Yang; Kai Liu; Mun Hong Ngai; Martin J Lear; Markus R Wenk; Shao Q Yao
Journal:  J Am Chem Soc       Date:  2010-01-20       Impact factor: 15.419

6.  Lipid droplet dynamics at early stages of Mycobacterium marinum infection in Dictyostelium.

Authors:  Caroline Barisch; Peggy Paschke; Monica Hagedorn; Markus Maniak; Thierry Soldati
Journal:  Cell Microbiol       Date:  2015-04-08       Impact factor: 3.715

7.  Mycobacterium tuberculosis expresses two chaperonin-60 homologs.

Authors:  T H Kong; A R Coates; P D Butcher; C J Hickman; T M Shinnick
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization.

Authors:  Sabine Daugelat; Jane Kowall; Jens Mattow; Dirk Bumann; Ralf Winter; Robert Hurwitz; Stefan H E Kaufmann
Journal:  Microbes Infect       Date:  2003-10       Impact factor: 2.700

9.  Characterization of an exported monoglyceride lipase from Mycobacterium tuberculosis possibly involved in the metabolism of host cell membrane lipids.

Authors:  Karen Côtes; Rabeb Dhouib; Isabelle Douchet; Henri Chahinian; Alain de Caro; Frédéric Carrière; Stéphane Canaan
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

10.  The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase.

Authors:  P Hadváry; W Sidler; W Meister; W Vetter; H Wolfer
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

View more
  9 in total

1.  The endogenous galactofuranosidase GlfH1 hydrolyzes mycobacterial arabinogalactan.

Authors:  Lin Shen; Albertus Viljoen; Sydney Villaume; Maju Joe; Iman Halloum; Loïc Chêne; Alexandre Méry; Emeline Fabre; Kaoru Takegawa; Todd L Lowary; Stéphane P Vincent; Laurent Kremer; Yann Guérardel; Christophe Mariller
Journal:  J Biol Chem       Date:  2020-02-27       Impact factor: 5.157

2.  Optimization of secretion and surface localization of heterologous OVA protein in mycobacteria by using LipY as a carrier.

Authors:  Maroeska J Burggraaf; Louis S Ates; Alexander Speer; Kim van der Kuij; Coen Kuijl; Wilbert Bitter
Journal:  Microb Cell Fact       Date:  2019-03-06       Impact factor: 5.328

3.  Nitrogen deprivation induces triacylglycerol accumulation, drug tolerance and hypervirulence in mycobacteria.

Authors:  Pierre Santucci; Matt D Johansen; Vanessa Point; Isabelle Poncin; Albertus Viljoen; Jean-François Cavalier; Laurent Kremer; Stéphane Canaan
Journal:  Sci Rep       Date:  2019-06-17       Impact factor: 4.379

4.  Dissecting the antibacterial activity of oxadiazolone-core derivatives against Mycobacterium abscessus.

Authors:  Abdeldjalil Madani; Ivy Mallick; Alexandre Guy; Céline Crauste; Thierry Durand; Patrick Fourquet; Stéphane Audebert; Luc Camoin; Stéphane Canaan; Jean François Cavalier
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

Review 5.  Metabolic Versatility of Mycobacterium tuberculosis during Infection and Dormancy.

Authors:  Dorothy Pei Shan Chang; Xue Li Guan
Journal:  Metabolites       Date:  2021-02-02

6.  Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: New insights into the regulation of mycolactone.

Authors:  Marie Robbe-Saule; Mélanie Foulon; Isabelle Poncin; Lucille Esnault; Hugo Varet; Rachel Legendre; Alban Besnard; Anna E Grzegorzewicz; Mary Jackson; Stéphane Canaan; Laurent Marsollier; Estelle Marion
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

7.  Quantitative Lipid Droplet Proteomics Reveals Mycobacterium tuberculosis Induced Alterations in Macrophage Response to Infection.

Authors:  Dilip Menon; Kaurab Singh; Sneha M Pinto; Ananya Nandy; Neetika Jaisinghani; Rintu Kutum; Debasis Dash; T S Keshava Prasad; Sheetal Gandotra
Journal:  ACS Infect Dis       Date:  2019-02-04       Impact factor: 5.084

Review 8.  Triacylglycerols: Fuelling the Hibernating Mycobacterium tuberculosis.

Authors:  Rahul Kumar Maurya; Suman Bharti; Manju Y Krishnan
Journal:  Front Cell Infect Microbiol       Date:  2019-01-09       Impact factor: 5.293

9.  Type VII Secretion Substrates of Pathogenic Mycobacteria Are Processed by a Surface Protease.

Authors:  Maroeska J Burggraaf; Alexander Speer; Aniek S Meijers; Roy Ummels; Astrid M van der Sar; Konstantin V Korotkov; Wilbert Bitter; Coenraad Kuijl
Journal:  mBio       Date:  2019-10-29       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.